Accreditation Statements

• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 3.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 3.0 continuing education contact hour(s). Nurses must attend the entire session within each day to receive credit. Partial session credit is prohibited and will be forfeited. 
• DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this live activity for a maximum of 3.0 continuing education contact hour(s).
• Other healthcare providers: This live activity is designated for 3.0 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No commercial interest company provided financial support for this continuing education activity.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.

• Anuj Bhargava, MD, MBA, CDE, FACP, FACE, Speaker
• Julie Baker, MPA, CHCEF, Planning Committee Member
• Laurene Hendricks, Planning Committee Member
• Carol Hibbs, Planning Committee Member
• Meredith Koob, Planning Committee Member
• Kate LaFollette, RN, Planning Committee Member
• Ann Loges, RN, Planning Committee Member
• Bethany Maen, Planning Committee Member
• Katie McBurney, BSHM, RDH, CPHQ, Speaker
• Andrew Minear, MPH, Planning Committee Member
• Wendy Mobley-Buckstein, Planning Committee Member
• Elizabeth Momany, MHA, PhD, Speaker
• Chris Parker, PharmD, BCACP, Speaker
• Rachel Patterson-Rahn, RDH, Speaker
• Trina Radske-Suchan, PT, CSCS, FMSC, Planning Committee Member
• Kady Reese, MPH, CPHQ, Planning Committee Member
• Cari Seddon, MA, RDN, LD, CDCES, Planning Committee Member
• Hannah Shultz, MA, Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.

• Matthew Dunn, Speaker, is an employee of Omada Health.
• Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, Speaker, is a consultant for Lifescan, Insulet, Lilly, and Companion Medical, and is also on the speaker's bureau for Abbott, Xeris Pharmaceuticals, Dexcom, and Novo Nordisk.
• Megan Munoz, RN, MSN, CMSRN, CDCES, Speaker, owns self-managed stock in Tandem and Dexcom.
• Jamie Pitlick, PharmD, Speaker, is a member of the speaker's bureau for Xeris (GVoke).
• Michael Turken, MD, MPH, Speaker, is an employee of Omada Health.

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.